Fig. 1: Patients plasma concentrations for crizotinib, PD-0325901 and PD-0315209.

Twenty-four hours PK profiles for crizotinib, obtained C1D21 (a), C1D28 (b), for PD-0325901 obtained C1D-1 (c) and C1D21 (d) and for PD-0315209 obtained C1D-1 (e) and C1D21 (f).